Nanjing Pharmaceutical Co., Ltd. logo

Nanjing Pharmaceutical Co., Ltd. (600713)

Market Closed
10 Aug, 06:57
SSE SSE
¥
5. 20
+0.02
+0.3861%
¥
6.34B Market Cap
- P/E Ratio
0.64% Div Yield
17.26M Volume
- Eps
¥ 5.18
Previous Close
Add Transaction
Day Range
5.14 5.25
Year Range
4.81 6.65
Want to track 600713 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600713 closed yesterday higher at ¥5.2, an increase of 0.3861% from Friday's close, completing a monthly increase of 4% or ¥0.2. Over the past 12 months, 600713 stock lost -5.2823%.
600713 pays dividends to its shareholders, with the most recent payment made on Jun 30, 2026. The next estimated payment will be in In 10 months on Jun 30, 2027 for a total of ¥0.17.
The last earnings report, released on May 30, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0176%, based on the last three reports.
Nanjing Pharmaceutical Co., Ltd. has completed 4 stock splits, with the recent split occurring on Jul 08, 2011.
The company's stock is traded on one exchange.

600713 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Nanjing Pharmaceutical Co., Ltd. (600713) FAQ

What is the stock price today?

The current price is ¥5.20.

On which exchange is it traded?

Nanjing Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600713.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.64%.

What is its market cap?

As of today, the market cap is 6.34B.

Has Nanjing Pharmaceutical Co., Ltd. ever had a stock split?

Nanjing Pharmaceutical Co., Ltd. had 4 splits and the recent split was on Jul 08, 2011.

Nanjing Pharmaceutical Co., Ltd. Profile

Health Care Providers & Services Industry
Healthcare Sector
Mr. Liang Zhang CEO
SSE Exchange
CNE000000KV1 ISIN
CN Country
4,903 Employees
30 Jun 2026 Last Dividend
8 Jul 2011 Last Split
7 Jun 1996 IPO Date

Overview

NanJing Pharmaceutical Company Limited is a prominent enterprise focused on the pharmaceutical sector in China. Established in 1951, the company has grown significantly over the years to encompass a robust range of operations primarily centered around pharmaceutical wholesale and retail activities. With its headquarters in Nanjing, China, NanJing Pharmaceutical Company has successfully expanded its reach across the country, providing essential pharmaceutical products and services to a vast demographic. Its enduring commitment to healthcare and the well-being of its customers has established it as a key player in the pharmaceutical industry within China.

Products and Services

  • Pharmaceutical Wholesale

    As a major component of its business model, NanJing Pharmaceutical Company Limited offers extensive wholesale services, distributing a wide array of pharmaceutical products to various healthcare institutions, pharmacies, and other retailers. This sector enables the efficient delivery of necessary medications and healthcare products across China, ensuring their availability to a broad customer base.

  • Pharmaceutical Retail

    Complementing its wholesale operations, the company also engages in the direct retail of pharmaceuticals through its physical stores. These outlets serve as crucial access points for consumers seeking reliable and high-quality healthcare products and advice. The retail outlets are staffed with knowledgeable pharmacists who provide valuable guidance and support to customers, further underscoring the company’s dedication to public health.

  • Operation of Pharmacies

    NanJing Pharmaceutical Company operates a network of pharmacies across China, offering a comprehensive range of medications, health supplements, and medical devices. These pharmacies play a pivotal role in making healthcare products accessible and affordable to the communities they serve. The presence of these pharmacies cements the company’s position as a pivotal healthcare provider in the region.

  • E-commerce Platform

    Acknowledging the shift towards digital platforms, the company has also ventured into e-commerce, allowing customers to conveniently purchase pharmaceutical and healthcare products online. This digital expansion enables NanJing Pharmaceutical Company to reach a wider audience, providing ease of access to their products for individuals who prefer online shopping. This e-commerce initiative represents the company's adaptation to modern consumer behaviors and technological advancements.

Contact Information

Address: Building A, Nanjing, China, 210012
Phone: 86 25 8455 2601